Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
University of California, San Diego
Tri-Service General Hospital
University of Arizona
Biozeus Biopharmaceutical S.A.
Washington University School of Medicine
Ottawa Hospital Research Institute
University of Miami
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Providence Health & Services
Radiation Therapy Oncology Group
University of Miami
Erasmus Medical Center
Erasmus Medical Center